Protein encapsulation by electrospinning and electrospraying

A Moreira, D Lawson, L Onyekuru… - Journal of controlled …, 2021 - Elsevier
Given the increasing interest in the use of peptide-and protein-based agents in therapeutic
strategies, it is fundamental to develop delivery systems capable of preserving the biological …

Nanomedicine progress in thrombolytic therapy

A Zenych, L Fournier, C Chauvierre - Biomaterials, 2020 - Elsevier
Thrombotic occlusions of blood vessels are responsible for life-threatening cardiovascular
disorders such as myocardial infarction, ischemic stroke, and venous thromboembolism …

Electrospraying an enabling technology for pharmaceutical and biomedical applications: A review

SK Boda, X Li, J Xie - Journal of aerosol science, 2018 - Elsevier
Electrospraying (ES) is a robust and versatile technique for the fabrication of micro-and
nanoparticulate materials of various compositions, morphologies, shapes, textures and …

Structured micro/nano materials synthesized via electrospray: a review

T He, JV Jokerst - Biomaterials Science, 2020 - pubs.rsc.org
The development of synthetic methods for micro/nano materials with precisely controlled
structures, morphologies, and local compositions is of great importance for the advancement …

Advanced drug delivery system against ischemic stroke

S Zhang, Y Zhou, R Li, Z Chen, X Fan - Journal of Controlled Release, 2022 - Elsevier
Ischemic stroke is a vascular central nervous system (CNS) disease that leads a disability
and death. Thrombolysis and neuroprotection are the primary treatment strategies of …

Antithrombotic Therapy by Regulating the ROS‐Mediated Thrombosis Microenvironment and Specific Nonpharmaceutical Thrombolysis Using Prussian Blue …

W Zhang, J Wang, Z Xie, H Zou, Q Chen, L Xu, L Hu… - Small, 2022 - Wiley Online Library
In thrombotic diseases, the effects of reactive oxygen species (ROS)‐mediated oxidative
stress as a “perpetrator” in thrombosis must be resolved. Accordingly, an insufficient …

Tissue plasminogen activator-based nanothrombolysis for ischemic stroke

S Liu, X Feng, R Jin, G Li - Expert opinion on drug delivery, 2018 - Taylor & Francis
Introduction: Thrombolysis with intravenous tissue plasminogen activator (tPA) is the only
FDA approved treatment for patients with acute ischemic stroke, but its use is limited by …

Review of bubble dynamics on charged liquid–gas flow

W Zhang, J Wang, Z Wang, B Li, K Yu, S Zhan… - Physics of …, 2023 - pubs.aip.org
When a fluid is subject to an electric field, it usually processes unique features compared to
the conventional fluid that arises from coupling between charged particles and fluid …

Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke

H Ma, Z Jiang, J Xu, J Liu, ZN Guo - Drug Delivery, 2021 - Taylor & Francis
Ischemic stroke is one of the major causes of severe disability and death worldwide. It is
mainly caused by a sudden reduction in cerebral blood flow due to obstruction of the …

Induction of enhanced immunogenic cell death through ultrasound-controlled release of doxorubicin by liposome-microbubble complexes

FY Huang, J Lei, Y Sun, F Yan, B Chen, L Zhang… - …, 2018 - Taylor & Francis
Immunogenic cell death (ICD) is a specific kind of cell death that stimulates the immune
system to combat cancer cells. Ultrasound (US)-controlled targeted release of drugs by …